Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000897069-25-001219
Filing Date
2025-07-28
Accepted
2025-07-28 16:32:43
Documents
1
Period of Report
2025-07-24

Document Format Files

Seq Description Document Type Size
1 form4.html 4  
1 form4.xml 4 4087
  Complete submission text file 0000897069-25-001219.txt   5568
Mailing Address 601 21ST STREET, SUITE 300 VERO BEACH FL 32960
Business Address 601 21ST STREET, SUITE 300 VERO BEACH FL 32960 443-776-3133
Processa Pharmaceuticals, Inc. (Issuer) CIK: 0001533743 (see all company filings)

EIN.: 451539785 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address 7380 COCA COLA DRIVE SUITE 106 HANOVER MD 21076
Business Address
Bigora Sian (Reporting) CIK: 0001799365 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-39531 | Film No.: 251156038